High expression of DNA methyltransferase 3A (DNMT3A) at the lncRNA SLERCC (Specific Low Expression in RCC) promoter site will result in abnormal hypermethylation, which ultimately leads to decreased SLERCC expression in RCC. This evidence concerns the gene DNMT3A and renal cell carcinoma.